Merck Stops Winrevair Study Early Amid Positive Results
Merck said the Phase 3 "Hyperion" study, which was evaluating Winrevair versus placebo in recently diagnosed adults with PAH at intermediate or high risk of disease progression, had lost clinical ...
Le Lézard50 分
Northern Trust Develops Capability to Create Digital Voluntary Carbon Credits in Near Real-Time
Northern Trust has announced a significant enhancement for the Voluntary Carbon Market (VCM) through the ability to generate digital voluntary carbon credits in near real-time on The Northern Trust ...
stockhead45 分
High Voltage: Indonickel production quotas an ingredient in the cocktail for a price rebound
Indonesia has cut nickel production quotas in a move Benchmark says could leave domestic smelters crying out for supply.
Investing49 分
FedEx shares fall as UPS outlook weighs on sector
FedEx (NYSE:FDX) stock tumbled 3.5% today after rival United Parcel Service Inc. (NYSE:UPS) released a revenue forecast that fell short of market expectations, signaling weaker demand in the parcel ...
Investing53 分
Meta raised at Benchmark on strong core business outlook
Benchmark upgraded Meta Platforms (NASDAQ:META) to Buy in a note Thursday, citing a strong 2025 core business outlook and the potential for long-term capital intensity reduction.  The firm raised its ...